药剂师对研讨会OTC助听器实施小组的反思
1American Pharmacists Association, Washington, District of Columbia.
Seminars in hearing
|April 28, 2025
概括
场外 (OTC) 助听器销售提供了各种实施模式. 一个研讨会小组讨论了药剂师,听力学家和消费者的观点,强调了跨专业合作的必要性.
科学领域:
- 听力学 听力学是指听力学.
- 药房实践 在药房实践.
- 消费者健康 消费者健康
背景情况:
- 非处方 (OTC) 助听器的出现为可访问性提供了新的途径.
- 了解OTC助听器的各种实施策略对于利益相关者来说至关重要.
- 之前的研究还没有完全捕捉到从各种专业和消费者的角度考虑的多方面问题.
研究的目的:
- 探索OTC助听器销售的各种实施模式.
- 综合药剂师,听力学家和消费者关于OTC助听器接入的观点.
- 强调专业间合作在成功整合OTC助听器方面的重要性.
主要方法:
- 在OTC助听器和自我护理研讨会上的小组讨论.
- 从药学,听力学和消费者倡导的代表那里收集了专家的见解.
- 文章是由小组主持人撰写的,提供了一个综合的概述.
主要成果:
- 有多种OTC助听器的实施途径,每个都有独特的挑战和好处.
- 成功实施的关键考虑因素包括专业角色,患者支持和监管框架.
- 药剂师,听力学家和消费者对OTC助听器的可访问性和使用有着不同的但相互关联的担忧.
结论:
- 顺利实施OTC助听器需要医疗保健专业人员和知情消费者之间的协作方法.
- 跨专业的合作对于解决OTC助听器市场的潜在障碍和优化患者结果至关重要.
- 需要进一步对话和制定战略,以确保公平有效地获得听力医疗保健解决方案.
相关概念视频
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...